Total Liabilities (Quarterly) Chart

View Total Liabilities (Quarterly) for PAIOF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Liabilities (Quarterly) Chart
Start Trial

Historical Total Liabilities (Quarterly) Data

View and export this data back to 2004. Start Trial.
Date Value
December 31, 2015 8.588M
September 30, 2015 6.906M
June 30, 2015 5.372M
March 31, 2015 4.118M
December 31, 2014 4.769M
September 30, 2014 3.518M
June 30, 2014 5.583M
March 31, 2014 5.070M
December 31, 2013 6.458M
September 30, 2013 7.108M
June 30, 2013 6.745M
March 31, 2013 15.25M
December 31, 2012 16.83M
September 30, 2012 16.18M
June 30, 2012 16.16M
March 31, 2012 17.30M
December 31, 2011 16.97M
September 30, 2011 17.92M
June 30, 2011 19.57M
March 31, 2011 20.08M
December 31, 2010 19.94M
September 30, 2010 20.22M
June 30, 2010 18.84M
Date Value
March 31, 2010 21.15M
December 31, 2009 23.31M
September 30, 2009 24.76M
June 30, 2009 24.10M
March 31, 2009 22.64M
December 31, 2008 17.53M
September 30, 2008 24.76M
June 30, 2008 36.29M
March 31, 2008 27.02M
December 31, 2007 14.40M
September 30, 2007 12.99M
June 30, 2007 35.19M
March 31, 2007 33.95M
December 31, 2006 32.34M
September 30, 2006 29.48M
June 30, 2006 26.06M
March 31, 2006 15.05M
December 31, 2005 15.72M
September 30, 2005 13.63M
June 30, 2005 11.81M
March 31, 2005 12.80M
December 31, 2004
September 30, 2004 6.082M

Total Liabilities Definition

Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.

Read full definition.

Total Liabilities (Quarterly) Range, Past 5 Years

View Total Liabilities (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Liabilities (Quarterly) Benchmarks

View Total Liabilities (Quarterly) Benchmarks
Start Trial
CureVac NV 314.18M
Anbio Biotechnology --
Epigenomics AG --
ACADIA Pharmaceuticals, Inc. 436.29M
Alkermes Plc 2.585B